0001209191-18-002065.txt : 20180104
0001209191-18-002065.hdr.sgml : 20180104
20180104171405
ACCESSION NUMBER: 0001209191-18-002065
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180102
FILED AS OF DATE: 20180104
DATE AS OF CHANGE: 20180104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RAAB MICHAEL
CENTRAL INDEX KEY: 0001321402
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33497
FILM NUMBER: 18511015
MAIL ADDRESS:
STREET 1: 1119 ST PAUL STREET
CITY: BALTIMORE
STATE: MD
ZIP: 21202
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMICUS THERAPEUTICS INC
CENTRAL INDEX KEY: 0001178879
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 200422823
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
BUSINESS PHONE: (609) 662-2000
MAIL ADDRESS:
STREET 1: 1 CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-01-02
0
0001178879
AMICUS THERAPEUTICS INC
FOLD
0001321402
RAAB MICHAEL
C/O AMICUS THERAPEUTICS, INC.
1 CEDAR BROOK DRIVE
CRANBURY
NJ
08512
1
0
0
0
Common Stock
2018-01-02
4
M
0
9366
15.00
A
15180
D
Common Stock
2018-01-02
4
S
0
9366
15.00
D
5814
D
Stock Options (right to buy)
2.81
2018-01-02
4
M
0
5000
0.00
D
2011-06-15
2020-06-15
Common Stock
5000
5000
D
Stock Options (right to buy)
7.51
2018-01-02
4
M
0
4366
0.00
D
2012-05-24
2021-05-24
Common Stock
4366
5634
D
The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 9, 2017.
This price of $15.00 is the sole purchase price for the transactions reported on this line.
This price of $15.00 is the sole sale price for the transactions reported on this line.
/s/ Michael G. Raab
2018-01-04